 Connection
Judith Shlay to Male
This is a "connection" page, showing publications Judith Shlay has written about Male.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.370 |
|
|
|
-
Arifkhanova A, McCormick Kraus E, Al-Tayyib A, Taub J, Encinias A, McEwen D, Davidson A, Shlay JC. Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital-Denver, Colorado, 2017. Drug Alcohol Depend. 2021 01 01; 218:108306.
Score: 0.031
-
Prieto JT, McEwen D, Davidson AJ, Al-Tayyib A, Gawenus L, Papagari Sangareddy SR, Blum J, Foldy S, Shlay JC. Monitoring opioid addiction and treatment: Do you know if your population is engaged? Drug Alcohol Depend. 2019 09 01; 202:56-60.
Score: 0.028
-
Bull S, Devine S, Schmiege SJ, Hammes A, Pickard L, Shlay JC. Text Messaging and Teen Sexual Health Behavior: Long-term Follow-up of a Cluster Randomized Trial. Comput Inform Nurs. 2017 Nov; 35(11):549-553.
Score: 0.025
-
Bull S, Devine S, Schmiege SJ, Pickard L, Campbell J, Shlay JC. Text Messaging, Teen Outreach Program, and Sexual Health Behavior: A Cluster Randomized Trial. Am J Public Health. 2016 09; 106(S1):S117-S124.
Score: 0.023
-
Albright K, Daley MF, Kempe A, Pyrzanowski J, Jimenez-Zambrano A, Campagna EJ, Shlay JC. Parent attitudes about adolescent school-located vaccination and billing. J Adolesc Health. 2014 Nov; 55(5):665-71.
Score: 0.020
-
Kempe A, Daley MF, Pyrzanowski J, Vogt T, Fang H, Rinehart DJ, Morgan N, Riis M, Rodgers S, McCormick E, Hammer A, Campagna EJ, Kile D, Dickinson M, Hambidge SJ, Shlay JC. School-located influenza vaccination with third-party billing: outcomes, cost, and reimbursement. Acad Pediatr. 2014 May-Jun; 14(3):234-40.
Score: 0.020
-
Kempe A, Daley MF, Pyrzanowski J, Vogt TM, Campagna EJ, Dickinson LM, Hambidge SJ, Shlay JC. School-located influenza vaccination with third-party billing: what do parents think? Acad Pediatr. 2014 May-Jun; 14(3):241-8.
Score: 0.020
-
Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolesc Health. 2014 Mar; 54(3):282-8.
Score: 0.020
-
Devine S, Bull S, Dreisbach S, Shlay J. Enhancing a Teen Pregnancy Prevention Program with text messaging: engaging minority youth to develop TOP ? Plus Text. J Adolesc Health. 2014 Mar; 54(3 Suppl):S78-83.
Score: 0.020
-
Shlay JC, McEwen D, Bell D, Maravi M, Rinehart D, Fang H, Devine S, Mickiewicz T, Dreisbach S. Integration of family planning services into a sexually transmitted disease clinic setting. Sex Transm Dis. 2013 Aug; 40(8):669-74.
Score: 0.019
-
McCormick EV, Durfee J, Vogt TM, Daley MF, Hambidge SJ, Shlay J. Physician attitudes regarding school-located vaccinations. Pediatrics. 2012 Nov; 130(5):887-96.
Score: 0.018
-
Shlay JC, Barber B, Mickiewicz T, Maravi M, Drisko J, Estacio R, Gutierrez G, Urbina C. Reducing cardiovascular disease risk using patient navigators, Denver, Colorado, 2007-2009. Prev Chronic Dis. 2011 Nov; 8(6):A143.
Score: 0.017
-
Shlay JC, Sharma S, Peng G, Gibert CL, Grunfeld C. The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009 Jul 01; 51(3):298-304.
Score: 0.014
-
Shlay JC, Sharma S, Peng G, Gibert CL, Grunfeld C. Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine. J Acquir Immune Defic Syndr. 2008 May 01; 48(1):53-62.
Score: 0.013
-
Shlay JC, Bartsch G, Peng G, Wang J, Grunfeld C, Gibert CL, Visnegarwala F, Raghavan SS, Xiang Y, Farrough M, Perry HE, Kotler D, El-Sadr WM. Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy. J Acquir Immune Defic Syndr. 2007 Apr 15; 44(5):506-17.
Score: 0.012
-
Shlay JC, Visnegarwala F, Bartsch G, Wang J, Peng G, El-Sadr WM, Gibert C, Kotler D, Grunfeld C, Raghavan S. Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine. J Acquir Immune Defic Syndr. 2005 Feb 01; 38(2):147-55.
Score: 0.010
-
Shlay JC, McClung MW, Patnaik JL, Douglas JM. Comparison of sexually transmitted disease prevalence by reported condom use: errors among consistent condom users seen at an urban sexually transmitted disease clinic. Sex Transm Dis. 2004 Sep; 31(9):526-32.
Score: 0.010
-
Shlay JC, McClung MW, Patnaik JL, Douglas JM. Comparison of sexually transmitted disease prevalence by reported level of condom use among patients attending an urban sexually transmitted disease clinic. Sex Transm Dis. 2004 Mar; 31(3):154-60.
Score: 0.010
-
Prieto JT, Scott K, McEwen D, Podewils LJ, Al-Tayyib A, Robinson J, Edwards D, Foldy S, Shlay JC, Davidson AJ. The Detection of Opioid Misuse and Heroin Use From Paramedic Response Documentation: Machine Learning for Improved Surveillance. J Med Internet Res. 2020 01 03; 22(1):e15645.
Score: 0.007
-
Devine S, Leeds C, Shlay JC, Leytem A, Beum R, Bull S. Methods to assess youth engagement in a text messaging supplement to an effective teen pregnancy program. J Biomed Inform. 2015 Aug; 56:379-86.
Score: 0.005
-
Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol. 2013 Aug; 19(4):383-92.
Score: 0.005
-
Soliman EZ, Lundgren JD, Roediger MP, Duprez DA, Temesgen Z, Bickel M, Shlay JC, Somboonwit C, Reiss P, Stein JH, Neaton JD. Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations. AIDS. 2011 Jan 28; 25(3):367-77.
Score: 0.004
-
Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, Shlay J, Drummond F, Pearce D, Edwards S, Reiss P, El-Sadr W, Carr A. The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. AIDS. 2010 Jan 28; 24(3):353-63.
Score: 0.004
-
Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, Martinez E, Reiss P, Visnegarwala F, Carr AD. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009 Jul 31; 23(12):1519-29.
Score: 0.004
-
Gibert CL, Shlay JC, Sharma S, Bartsch G, Peng G, Grunfeld C. Racial differences in changes of metabolic parameters and body composition in antiretroviral therapy-naive persons initiating antiretroviral therapy. J Acquir Immune Defic Syndr. 2009 Jan 01; 50(1):44-53.
Score: 0.003
-
Tedaldi EM, Absalon J, Thomas AJ, Shlay JC, van den Berg-Wolf M. Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study). J Acquir Immune Defic Syndr. 2008 Apr 01; 47(4):441-8.
Score: 0.003
-
Visnegarwala F, Shlay JC, Barry V, Gibert CL, Xiang Y, Wang J, Kotler D, Raghavan S, El-Sadr WM. Effects of HIV infection on body composition changes among men of different racial/ethnic origins. HIV Clin Trials. 2007 May-Jun; 8(3):145-54.
Score: 0.003
-
Visnegarwala F, Raghavan SS, Mullin CM, Bartsch G, Wang J, Kotler D, Gibert CL, Shlay J, Grunfeld C, Carr A, El-Sadr W. Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons. Am J Clin Nutr. 2005 Oct; 82(4):850-6.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|